0
0
0
Synthetic Biology and Active Pharmaceutical Ingredients Act
1/25/2024, 8:00 PM
Read the Full Bill
Current Status of Bill HR 6897
Bill HR 6897 is currently in the status of Bill Introduced since December 22, 2023. Bill HR 6897 was introduced during Congress 118 and was introduced to the House on December 22, 2023. Bill HR 6897's most recent activity was Referred to the House Committee on Armed Services. as of December 22, 2023
Bipartisan Support of Bill HR 6897
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
1Democrat Cosponsors
0Republican Cosponsors
1Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 6897
Primary Policy Focus
HealthAlternate Title(s) of Bill HR 6897
Synthetic Biology and Active Pharmaceutical Ingredients Act
Synthetic Biology and Active Pharmaceutical Ingredients Act
To require the Secretary of Defense to establish a pilot program to evaluate novel pharmaceutical manufacturing technologies to reduce the reliance of the Department on foreign manufacturers for active pharmaceutical ingredients and key starting materials.
Comments
Sponsors and Cosponsors of HR 6897
Latest Bills
Quantum Instrumentation for Science and Engineering Act
Bill HR 8237April 11, 2026
American Homes First Act
Bill S 4240April 11, 2026
NO TOD Act
Bill HR 8230April 11, 2026
Save Struggling Hospitals Act
Bill S 4233April 11, 2026
HOPE with Fertility Services Act
Bill HR 8119April 11, 2026
Books Save Lives Act
Bill HR 8235April 11, 2026
Endless Mountains National Heritage Area Act
Bill S 4238April 11, 2026
Virtual Readiness Act of 2026
Bill HR 8243April 11, 2026
Veterans Benefits Information Protection Act
Bill HR 8120April 11, 2026
CFTC Proprietary Information Act of 2026
Bill HR 8125April 11, 2026